NCT06402058View on ClinicalTrials.gov

A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions
Crow's Feet Lines
Interventions
DEVICE

DMSB01

Apply a maximum of 1.0 ml for each side of the Crow's Feet Lines using both the test device (DMSB01) and the control device (Rejuran®).

DEVICE

Rejuran®

Apply a maximum of 1.0 ml for each side of the Crow's Feet Lines using both the test device (DMSB01) and the control device (Rejuran®).

All Listed Sponsors
lead

Samyang Biopharmaceuticals Corporation

INDUSTRY

NCT06402058 - A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement | Biotech Hunter | Biotech Hunter